Acelyrin Inc (NASDAQ:SLRN) price on Thursday, April 10, fall -1.15% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $2.15.
A look at the stock’s price movement, the close in the last trading session was $2.17, moving within a range at $2.05 and $2.18. Turning to its 52-week performance, $7.25 and $1.85 were the 52-week high and 52-week low respectively. Overall, SLRN moved -21.82% over the past month.
Acelyrin Inc’s market cap currently stands at around $216.95 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-18.
Turning to the stock’s technical picture we see that short term indicators suggest on average that SLRN is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
14 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 5 analyst(s) rate the stock as a Hold, 9 recommend SLRN as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
SLRN’s current price about -15.69% and -10.85% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 37.02, while 7-day volatility ratio is 12.02% and 7.08% in the 30-day chart. Further, Acelyrin Inc (SLRN) has a beta value of 1.16, and an average true range (ATR) of 0.19. Analysts have given the company’s stock an average 52-week price target of $15, forecast between a low of $15 and high of $15. Looking at the price targets, the low is -597.67% off current price level while to achieve the yearly target high, price needs to move -597.67%. Nonetheless, investors will most likely welcome a -597.67% jump to $15 which is the analysts’ median price.
If we refocus on Acelyrin Inc (NASDAQ:SLRN), historical trading data shows that trading volumes averaged 1.27 over the past 10 days and 1.98 million over the past 3 months. The company’s latest data on shares outstanding shows there are 100.45 million shares.
The 27.51% of Acelyrin Inc’s shares are in the hands of company insiders while institutional holders own 75.90% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 4.68 million on 2025-03-14, giving us a short ratio of 1.78. The data shows that as of 2025-03-14 short interest in Acelyrin Inc (SLRN) stood at 505.00000000000006 of shares outstanding, with shares short falling to 4.72 million registered in 2025-02-14. Current price change has pushed the stock -31.53% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the SLRN stock continues to rise going into the next quarter.
